Home/Kinea Bio/Seung Wook Oh, PhD

SW

Seung Wook Oh, PhD

Chief Operating Officer

Therapeutic Areas

Neuromuscular Diseases

Kinea Bio Pipeline

Drug	Indication	Phase
DMD Gene Therapy	Duchenne Muscular Dystrophy	Pre-clinical
Dysferlinopathy Gene Therapy	Dysferlinopathy (LGMD2B/LGMDR2)	Pre-clinical
DM1 Therapy	Myotonic Dystrophy Type 1	Research

Leadership Team at Kinea Bio

Martin K. (Casey) Childers, DO, PhD

Chief Executive Officer

Jeffrey Chamberlain, PhD

Co-founder, Chief Scientific Advisor

Michael Cho, JD

Chief Financial Officer, Chief Strategy Officer, General Counsel

View full Kinea Bio profile